Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study
According to our preliminary results, Lu-PRRT administered intensively could be considered as safe as the standard schedule, when TCA is chosen according to the RF. Further data are needed to confirm these results.
Authors
- Manuela Monti (ORCID: https://orcid.org/0000-0002-3587-1768)
- Irene Marini (ORCID: https://orcid.org/0009-0002-6186-688X)
- Lucia Fabbri
- Valentina Di Iorio (ORCID: https://orcid.org/0000-0002-5380-6185)
- Nicoletta Ranallo (ORCID: https://orcid.org/0000-0002-0799-7339)
- Ilaria Grassi (ORCID: https://orcid.org/0000-0002-9566-7670)
- Stefano Severi (ORCID: https://orcid.org/0000-0003-1846-0681)
- Silvia Nicolini (ORCID: https://orcid.org/0000-0002-3960-7737)
- Anna Sarnelli (ORCID: https://orcid.org/0000-0001-5986-3845)
- Maddalena Sansovini (ORCID: https://orcid.org/0000-0002-7699-262X)
- Federica Matteucci (ORCID: https://orcid.org/0000-0001-7455-6253)
- Lorenzo Fantini
- Giovanni Paganelli (ORCID: https://orcid.org/0000-0002-2631-4652)
- Flavia Foca (ORCID: https://orcid.org/0000-0002-5529-4769)
- Alice S. Rossi (ORCID: https://orcid.org/0000-0001-8717-0675)
Institutions
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Neuroendocrinology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1159/000542328
- Citations
- 2
- Primary Topic
- Medical Imaging and Pathology Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Ministero della Salute